These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11368435)

  • 1. Differential expression of chemokine receptors in B cell malignancies.
    Dürig J; Schmücker U; Dührsen U
    Leukemia; 2001 May; 15(5):752-6. PubMed ID: 11368435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor expression in B-cell lymphoproliferative disorders.
    Wong S; Fulcher D
    Leuk Lymphoma; 2004 Dec; 45(12):2491-6. PubMed ID: 15621766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
    López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
    J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
    Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
    Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia.
    Jones D; Benjamin RJ; Shahsafaei A; Dorfman DM
    Blood; 2000 Jan; 95(2):627-32. PubMed ID: 10627472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis.
    Trentin L; Agostini C; Facco M; Piazza F; Perin A; Siviero M; Gurrieri C; Galvan S; Adami F; Zambello R; Semenzato G
    J Clin Invest; 1999 Jul; 104(1):115-21. PubMed ID: 10393705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation-dependent modulation of B lymphocyte migration to chemokines.
    Brandes M; Legler DF; Spoerri B; Schaerli P; Moser B
    Int Immunol; 2000 Sep; 12(9):1285-92. PubMed ID: 10967023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.
    Deutsch AJ; Aigelsreiter A; Steinbauer E; Frühwirth M; Kerl H; Beham-Schmid C; Schaider H; Neumeister P
    J Pathol; 2008 Aug; 215(4):431-44. PubMed ID: 18561120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomas.
    Rodig SJ; Jones D; Shahsafaei A; Dorfman DM
    Hum Pathol; 2002 Dec; 33(12):1227-33. PubMed ID: 12514792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.
    Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T
    J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas.
    Trentin L; Cabrelle A; Facco M; Carollo D; Miorin M; Tosoni A; Pizzo P; Binotto G; Nicolardi L; Zambello R; Adami F; Agostini C; Semenzato G
    Blood; 2004 Jul; 104(2):502-8. PubMed ID: 15001469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human B cells immortalized with Epstein-Barr virus upregulate CCR6 and CCR10 and downregulate CXCR4 and CXCR5.
    Nakayama T; Fujisawa R; Izawa D; Hieshima K; Takada K; Yoshie O
    J Virol; 2002 Mar; 76(6):3072-7. PubMed ID: 11861876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
    Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
    Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
    Rasmussen T; Lodahl M; Hancke S; Johnsen HE
    Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
    Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
    Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of beta 1 integrins in normal B lymphocytes at different stages of development and in B cell neoplasias].
    Eichelmann A; Koretz K; Mechtersheimer G; Möller P
    Verh Dtsch Ges Pathol; 1992; 76():230-6. PubMed ID: 1283265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.